Diamond Hill Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.1M Sell
475,941
-68,093
-13% -$2.45M 0.18% 102
2026
Q1
$13.3M Buy
544,034
+111,308
+26% +$2.64M 0.08% 120
2025
Q4
$10.7M Buy
432,726
+71,462
+20% +$1.9M 0.06% 127
2025
Q3
$10.2M Buy
361,264
+89,733
+33% +$2.43M 0.05% 127
2025
Q2
$6.76M Buy
271,531
+60,493
+29% +$1.7M 0.03% 133
2025
Q1
$6.54M Buy
211,038
+51,827
+33% +$1.73M 0.03% 127
2024
Q4
$5.02M Buy
159,211
+16,911
+12% +$803K 0.02% 137
2024
Q3
$8.24M Buy
142,300
+38,826
+38% +$1.91M 0.03% 129
2024
Q2
$4.2M Buy
+103,474
New +$4.1M 0.02% 140

Other funds holding ASTH

Diamond Hill Capital Management's ASTH Position: Q2 2026 in Review

Diamond Hill Capital Management reduced its Astrana Health (ASTH) stake by 13% in Q2 2026, selling an estimated $2.45M and leaving 475,941 shares worth $22.1M. The position accounts for 0.18% of the portfolio, ranked #102.

Diamond Hill Capital Management first reported a position in ASTH in Q2 2024 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Diamond Hill Capital Management held 475,941 shares of Astrana Health worth $22.1M as of Q2 2026.
  • Diamond Hill Capital Management sold 68,093 Astrana Health shares in Q2 2026, an estimated $2.45M.
  • Astrana Health made up 0.18% of Diamond Hill Capital Management's portfolio in Q2 2026, its #102 holding.
  • Diamond Hill Capital Management first reported a position in Astrana Health in Q2 2024 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Diamond Hill Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.